GANX
Gain Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.43
-0.32 ▼ -11.64%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$2.46
+0.03 ▲ +1.19%
| Index | - | P/E | - | EPS (ttm) | -0.64 | Insider Own | 3.4% | Shs Outstand | 0.04B | Perf Week | -20.33% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | -9.63% | Insider Trans | - | Shs Float | 0.04B | Perf Month | 39.66% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | -0.14 | Inst Own | 21.38% | Short Float | 7.76% | Perf Quarter | -41.87% |
| Income | -0.02B | P/S | - | EPS this Y | 27.64% | Inst Trans | 12.75% | Short Ratio | 2.37 | Perf Half Y | 41.28% |
| Sales | 0.00B | P/B | 14.79 | EPS next 5Y | 2.3% | ROA | -153.07% | Short Interest | 2.88M | Perf YTD | -24.53% |
| Book/sh | 0.16 | P/C | 10.61 | EPS past 3/5Y | 13.25% -37.02% | ROE | -261.72% | 52W High | -44.01% ($4.34) | Perf Year | 10.45% |
| Cash/sh | 0.23 | P/FCF | - | Sales past 3/5Y | - | ROIC | -309.12% | 52W Low | 72.34% ($1.41) | Perf 3Y | -41.16% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 42.29% | Gross Margin | - | Volatility(W/M) | 9.83% 9.82% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.24 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.52 | EPS Q/Q | 10.7% | Profit Margin | - | RSI (14) | 49.42 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.52 | Sales Q/Q | - | SMA20 | -0.76% ($2.45) | Beta | -0.04 | Target Price | $7.6 |
| Payout | - | Debt/Eq | 0.1 | Earnings | 11000000 | SMA50 | 8.63% ($2.24) | Rel Volume | 1.04 | Prev Close | $2.75 |
| Employees | 25 | LT Debt/Eq | 0.06 | EPS/Sales Surpr. | 6.89% - | SMA200 | 13.08% ($2.15) | Avg Volume(3M) | 1.22M | Price | $2.43 |
| IPO | 2021/3/18 | Option/Short | Yes/Yes | Trades | 4105 | Volume | 1,263,002 | Change | -11.64% |
뉴스 로딩 중...